University of Miami: Clinical Trial Explores Effectiveness of New Treatment for Patients With Bladder Cancer
December 04, 2019
December 04, 2019
MIAMI, Florida, Dec. 4 -- The University of Miami's Miller School of Medicine issued the following news:
Urologic cancer experts at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are leading a clinical trial study for patients with non-muscle invasive bladder cancer (NMIBC) that has failed previous therapy. The Phase 2 trial examines whether the drug ALT-803, when added to the standard of care, the Bacillus Calmette-Guerin (BCG) vaccine, c . . .
Urologic cancer experts at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are leading a clinical trial study for patients with non-muscle invasive bladder cancer (NMIBC) that has failed previous therapy. The Phase 2 trial examines whether the drug ALT-803, when added to the standard of care, the Bacillus Calmette-Guerin (BCG) vaccine, c . . .